Identification of platelet-derived growth factor D in human chronic allograft nephropathy

Gang Liu1, Siribha Changsirikulchai, Kelly L Hudkins

  • 1Institute of Nephrology, Peking University, First Hospital, 100034 Beijing, China.

Human Pathology
|January 12, 2008
PubMed

Insights

Platelet-derived growth factor D (PDGF-D) is present in arteries affected by chronic allograft nephropathy (CAN), potentially driving injury. PDGF-D may also contribute to interstitial damage in kidney transplants.

Area of Science:

  • Nephrology
  • Immunology
  • Vascular Biology

Background:

  • Chronic allograft nephropathy (CAN) is the primary cause of late kidney transplant failure.
  • The specific mediators driving CAN progression remain largely unknown.

Purpose of the Study:

  • To investigate the role of platelet-derived growth factor D (PDGF-D) and its receptor PDGF-Rbeta in the pathogenesis of CAN.
  • To identify the cellular sources and localization of PDGF-D and PDGF-Rbeta in CAN.

Main Methods:

  • Immunohistochemistry was used to detect PDGF-D and PDGF-Rbeta expression in kidney allograft nephrectomies from patients with CAN, normal renal tissues, and biopsies with acute vascular rejection (AVR).
  • Double and triple immunohistochemistry identified cell types expressing PDGF-D.

Main Results:

  • PDGF-D was significantly expressed in the neointima of arteries with CAN-associated arteriopathy.
  • Neointimal cells expressing PDGF-D were identified as alpha-smooth muscle actin-positive cells.
  • PDGF-Rbeta was co-localized with PDGF-D in the neointima and more abundant in interstitial cells in the CAN group.

Conclusions:

  • PDGF-D, acting via PDGF-Rbeta in the neointima, likely promotes mesenchymal cell proliferation and neointima formation in CAN.
  • PDGF-D may also contribute to interstitial injury in chronic allograft injury, though its interstitial source is unclear.